US 10927182
Humanized BCMA antibody and BCMA-CAR-T cells
granted A61KA61K2035/124A61K2039/505
Quick answer
US patent 10927182 (Humanized BCMA antibody and BCMA-CAR-T cells) held by Caribou Biosciences, Inc. expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Caribou Biosciences, Inc.
- Grant date
- Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2035/124, A61K2039/505, A61K2039/54, A61K2039/804